4A-5P Analysis
Active Model
Tuberculosis Philippines
Data Source
Updated 2026-02-04
Source NTP-DOH, WHO TB Reports 2024-2025, RITM, PhilHealth
Year
Region
Case
Executive SummaryAvailablenessAdoptionAwarenessAffordabilityConceptualBottleneck MatrixStrategic RecommendationsLeaky BucketConceptualEvidence AuditFact Sheet
AVAIL 40%
ADOPT 37%
AWARE 75%
AFFORD 58%
MIN 37%

Leaky Bucket

Diagnostic cascade attrition analysis

Regional compare view: all 18 regions plus national total. Stage 1, 2, 6, and 8 are fact-backed where available; remaining stage values may be inferred from conversion assumptions or fallback defaults.

Philippines (Total)

2024
S1: Population at Risk (Prevalence)
724,000
A
S2: Symptomatic / Suspects
544,948 (78%)
A
-22% lost
S3: Seeking Care (Any Provider)
425,059 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
359,040 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
143,616 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
130,928 (94%)
A
-6% lost

BARMM

2024
S1: Population at Risk (Prevalence)
724,000
A
S2: Symptomatic / Suspects
544,948 (78%)
A
-22% lost
S3: Seeking Care (Any Provider)
425,059 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
7,768 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
3,107 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
2,808 (94%)
A
-6% lost

CALABARZON

2024
S1: Population at Risk (Prevalence)
111,903
B
S2: Symptomatic / Suspects
84,228 (78%)
B
-22% lost
S3: Seeking Care (Any Provider)
65,698 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
47,674 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
19,070 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
20,011 (94%)
A
-6% lost

CAR

2024
S1: Population at Risk (Prevalence)
7,525
B
S2: Symptomatic / Suspects
5,664 (78%)
B
-22% lost
S3: Seeking Care (Any Provider)
4,418 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
6,711 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
2,684 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
1,366 (94%)
A
-6% lost

MIMAROPA

2024
S1: Population at Risk (Prevalence)
21,921
B
S2: Symptomatic / Suspects
16,500 (78%)
B
-22% lost
S3: Seeking Care (Any Provider)
12,870 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
10,924 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
4,370 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
4,085 (94%)
A
-6% lost

NCR

2024
S1: Population at Risk (Prevalence)
141,657
B
S2: Symptomatic / Suspects
106,624 (78%)
B
-22% lost
S3: Seeking Care (Any Provider)
83,167 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
81,298 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
32,519 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
24,941 (94%)
A
-6% lost

NIR

2024
S1: Population at Risk (Prevalence)
724,000
A
S2: Symptomatic / Suspects
544,948 (78%)
A
-22% lost
S3: Seeking Care (Any Provider)
425,059 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
13,651 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
5,460 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
6,256 (94%)
A
-6% lost

Region 1

2024
S1: Population at Risk (Prevalence)
724,000
A
S2: Symptomatic / Suspects
544,948 (78%)
A
-22% lost
S3: Seeking Care (Any Provider)
425,059 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
12,156 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
4,862 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
5,600 (94%)
A
-6% lost

Region 2

2024
S1: Population at Risk (Prevalence)
724,000
A
S2: Symptomatic / Suspects
544,948 (78%)
A
-22% lost
S3: Seeking Care (Any Provider)
425,059 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
15,531 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
6,212 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
4,641 (94%)
A
-6% lost

Region 3

2024
S1: Population at Risk (Prevalence)
84,311
B
S2: Symptomatic / Suspects
63,460 (78%)
B
-22% lost
S3: Seeking Care (Any Provider)
49,499 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
33,765 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
13,506 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
15,117 (94%)
A
-6% lost

Region 5

2024
S1: Population at Risk (Prevalence)
724,000
A
S2: Symptomatic / Suspects
544,948 (78%)
A
-22% lost
S3: Seeking Care (Any Provider)
425,059 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
24,576 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
9,830 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
7,320 (94%)
A
-6% lost

Region 6

2024
S1: Population at Risk (Prevalence)
724,000
A
S2: Symptomatic / Suspects
544,948 (78%)
A
-22% lost
S3: Seeking Care (Any Provider)
425,059 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
14,096 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
5,638 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
6,028 (94%)
A
-6% lost

Region 7

2024
S1: Population at Risk (Prevalence)
724,000
A
S2: Symptomatic / Suspects
544,948 (78%)
A
-22% lost
S3: Seeking Care (Any Provider)
425,059 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
22,590 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
9,036 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
7,246 (94%)
A
-6% lost

Region 8

2024
S1: Population at Risk (Prevalence)
724,000
A
S2: Symptomatic / Suspects
544,948 (78%)
A
-22% lost
S3: Seeking Care (Any Provider)
425,059 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
11,659 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
4,664 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
4,270 (94%)
A
-6% lost

Region 9

2024
S1: Population at Risk (Prevalence)
724,000
A
S2: Symptomatic / Suspects
544,948 (78%)
A
-22% lost
S3: Seeking Care (Any Provider)
425,059 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
10,156 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
4,062 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
3,804 (94%)
A
-6% lost

Region 10

2024
S1: Population at Risk (Prevalence)
724,000
A
S2: Symptomatic / Suspects
544,948 (78%)
A
-22% lost
S3: Seeking Care (Any Provider)
425,059 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
10,074 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
4,030 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
4,305 (94%)
A
-6% lost

Region 11

2024
S1: Population at Risk (Prevalence)
724,000
A
S2: Symptomatic / Suspects
544,948 (78%)
A
-22% lost
S3: Seeking Care (Any Provider)
425,059 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
12,466 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
4,986 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
4,601 (94%)
A
-6% lost

Region 12

2024
S1: Population at Risk (Prevalence)
724,000
A
S2: Symptomatic / Suspects
544,948 (78%)
A
-22% lost
S3: Seeking Care (Any Provider)
425,059 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
11,331 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
4,532 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
5,250 (94%)
A
-6% lost

Region 13

2024
S1: Population at Risk (Prevalence)
724,000
A
S2: Symptomatic / Suspects
544,948 (78%)
A
-22% lost
S3: Seeking Care (Any Provider)
425,059 (78%)
C
-22% lost
S4: Correct Provider (RHU/Hospital)
315,000 (70%)
C
-30% lost
S5: Specimen Collected
220,500 (70%)
C
-30% lost
S6: Test Completed (GeneXpert/DSSM)
12,614 (82%)
A
-18% lost
S7: Bacteriologically Confirmed
5,046 (40%)
C
-60% lost
S8: Lab-confirmed Notified to ITIS
3,240 (94%)
A
-6% lost